Trump Plans 200% Tariff on Generic Drugs

President Donald Trump announced a plan to impose tariffs of up to 200% on imported generic medicines, giving manufacturers two years to shift production to the United States.

Indian pharmaceutical stocks fell sharply, with major drugmakers reassessing supply chains and investment plans.

Shares in European and Asian generic-drug makers also tumbled after the announcement.

The phased framework would start with zero tariffs for two years before escalating to 100% and then 200%, sending shockwaves through global pharmaceutical markets.